: Prot #RNLC3132: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C)

Project: Research project

Project Details

StatusActive
Effective start/end date1/12/241/12/27

Funding

  • Quintiles, Inc. (Prot #RNLC3132 // Prot #RNLC3132)
  • Salix Pharmaceuticals, Inc. (Prot #RNLC3132 // Prot #RNLC3132)